Clark Laboratories, Inc. (dba,Trinity Biotech USA)
FDA classification date
Sep 12, 2016
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class III
Reason stated in the source
The product lot failed to meet QC acceptance criteria during stability testing. The Calibrator OD was dropping causing the positive control to be invalid (running high out of range).
Source facts
Action
Recall notification letters (dated 7/11/2016) were sent by FedEx on 7/11/2016. Customers were instructed to discontinue use of any remaining inventory (discard on site if any remaining). Customers were also advised that if the test resulted in a valid run, such that all Controls and Calibrator met the Quality Control Criteria as stated in the package insert, the patient results can be reported and a re-evaluation of patient results is not necessary. For questions, please contact Trinity Biotech's Help Desk at 1-800-325-3424 Option #3.
Initiated
2016-07-11
Root cause
Nonconforming Material/Component
Terminated
2017-05-09
Distribution
Distribution to US nationwide including California, and China (Hong Kong).
Recall number
Z-2782-2016
Recall status
Terminated
CDRH record ID
148847
FDA classified
2016-09-12
Recall event number
74932
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.